Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-03-12
1987-06-30
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61U 3140
Patent
active
046771328
ABSTRACT:
A method for modifying the balance between bone production and bone resorption in a host animal by administration of etodolac to inhibit bone resorption.
REFERENCES:
patent: 3939178 (1976-02-01), Demerson et al.
patent: 4076831 (1976-02-01), Demerson
patent: 4533551 (1985-08-01), Martel
R. D. Williams et al., Science, 227, 640-642 (1985).
V. Maresca, J. Int. Med. Res. 13, 311-316 (1985).
W. A. Peck et al., J. of the Amer. Med. Assoc., 252, 799-802 (1984).
Ferdinandi et al., J. of Pharm. & Experimental Therepeutics, 220, 417-426 (1982).
American Home Products Corporation
Friedman Stanley J.
Routh John W.
LandOfFree
Inhibition of bone resorption by etodolac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of bone resorption by etodolac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of bone resorption by etodolac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-448009